CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Clinical trial NCT01540604 · COMPLETED

Trial details

NCT number: NCT01540604
Sponsor: RSPR Pharma AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy Becker Muscular Dystrophy

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.